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Abstract 
Objective: To investigate the differences of receptor activator of nuclear factor-κB ligand (RANKL) and 
Osteoprotegerin (OPG) expressions between normoglycemic and hyperglycemic Wistar rats (Rattus 
Novergicus) during Orthodontic Tooth Movement (OTM). Material and Methods: This study was true 
experimental with post-test group only. Thirty-two healthy male Wistar rats, weighted around 200-250 
grams, 12-20 weeks old, were used as OTM animal study. They were divided into 2 groups (n=16), 
normoglycemic rats (normal blood glucose 80-120 mg/dl) and hyperglycemic rats (>250 mg/dl) induced by 
Streptozotocin with a dose of 30 mg in PBS injection intraperitoneally. A NiTi closed coil spring was 
mounted between maxillary first molar and incisors with the light force 10gf/mm2 in both groups to induce 
OTM. The studied animals were then terminated on days 1, 3, 6, and 9, respectively, and premaxilla was 
extracted. RANKL and OPG expression were examined utilizing immunohistochemistry (IHC) analysis. 
One-way ANOVA and Tukey HSD (p<0.05) were utilized to analyze the differences in the expression of 
RANKL and OPG between groups. Results: The hyperglycemic group on day 1, 9 rats showed a significant 
increase in the expression of RANKL, whereas OPG expression decreased significantly on days 1, 3, and 9. 
Conclusion: There was a significant increase of RANKL expression and a decrease of OPG expression in 
hyperglycemic rats as documented immunohistochemically. 
 
Keywords: Diabetes Mellitus; Hyperglycemia; Orthodontics; Streptozotocin; RANK Ligand.
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Introduction 
Age and medical history are important points that dentists should consider before starting any 
orthodontic tretament in hyperglycemic patients. A metabolic disorder is one of the highly considered 
conditions in patients prior to hyperglycemic that often occurs in daily practice such as hyperglycemia. Chronic 
hyperglycemia can cause various complications, and it is commonly caused by Diabetes Mellitus (DM) type I. 
The most commonly found case is that patients do not realize that they have DM; thus, most of them are found 
in clinics at an advanced stage, or this condition can arise after an orthodontic hyperglycemic is performed 
[1,2]. 
The incidence of DM can occur in all age groups. The incidence of type I diabetes is usually found at 
the age of 14 years; therefore, DM type I is also called juvenile diabetes mellitus. In addition, the incidence of 
type II DM is usually found in patients aged 30 years and over, and the most commonly found are patients 
with an age range of 50-60 years. The number of people with type II DM covers about 90% of the total number 
of people with DM [3-5]. World Health Organization (WHO) reported that the number of people with DM in 
Indonesia would increase about 250% from 5 million in 1995 to 12 million in 2025. DM, as a chronic disease, 
can also cause bone metabolic disorder, which is a decrease in bone mass and quality [6,7]. 
One reported mechanism that explains the changes in bone remodeling in hyperglycemia is reduced 
bone formation due to decreased osteoblastic activity or increased apoptosis of osteoblasts and increased 
resorption activity in bone [8-10]. Changes in individual metabolism, which can interfere with bone 
remodeling, can produce the differences in the rate of orthodontic tooth movement (OTM) [11,12]. Even 
though the exact molecular mechanism is still not elucidated, hyperglycemia is considered may able to increase 
the production of macrophage colony-stimulating factor (MCSF), tumor necrosis factor-α (TNF-α), and 
receptor activator of nuclear factor-kappa ligand (RANKL), which are all crucial factors in proliferation and 
osteoclast differentiation [13,14]. Therefore, hyperglycemia may affect tooth movement during orthodontic 
hyperglycemic. The previous study found that the hyperglycemic condition in DM extends the duration of 
periodontal ligament degradation and alveolar bone resorption, where bone remodeling occurs in prolonged 
time [2,15]. 
At the cellular level, bone remodeling consists of bone resorption at the compression area and bone 
formation in the tensile area. Several factors play a role in bone remodeling during OTM, one of which is a 
chemical mediator such as cytokines and growth factors that might affect osteoblasts and osteoclasts activity 
[12,16,17]. RANKL and osteoprotegerin (OPG) are important factors in bone remodeling. RANKL plays a 
role in bone resorption. RANK will bind osteoclast precursors, which activate osteoclasts, and then bone 
resorption occurs. Meanwhile, OPG inhibits bone resorption by binding to RANKL; thus, it does not bind to 
RANK [18]. Considering the exact mechanism of cellular and molecular remodeling in hyperglycemia, which 
is not yet elucidated, this study was expected to provide an overview of the differences in RANKL and OPG 
expression between hyperglycemia and normal glucose level condition in an animal model. The aim of this 
study was to investigate the differences of RANKL and OPG expressions immunohistochemically between 
normoglycemic and hyperglycemic Wistar rats (Rattus Novergicus) during OTM. 
 
Material and Methods 
Study Design 
All experimental procedures involving animals were carried out in keeping with animal research: 
reporting of in vivo experiments (ARRIVE) guidelines to enhance any animal suffering. 
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This study was true experimental with post-test group only. The sample was chosen by using the 
simple blind random sampling, and the minimum sample size formula determined the sample size. We used 32 
healthy male Wistar rats (Rattus Novergicus), weighted around 200-250 grams, and aged around 12-20 weeks 
old. All the rats were caged individually in polycarbonate cages (0.90 × 0.60 × 0.60 m) for a week on a 12-h 
light/dark cycle at a steady temperature of 25°C and humidity of 50% for acclimatization to compensate their 
various origins. Animals were fed by using a standard pellet diet with ad libitum tap water and were routinely 
inspected for food consumption and fecal characteristics. The 32 samples were divided into 2 groups (n=16): 
normoglycemic rats (N) (normal blood glucose 80-120 mg/dl) and hyperglycemic rats (H) (>250 mg/dl) 
induced with Streptozotocin (Sigma Aldrich Inc., St. Louis, MO, USA) at the dose of 30 mg in PBS injection 
intraperitoneally. In rats, hyperglycemic condition was confirmed if the blood sugar levels ≥ 250 mg / dL 
checked using Accucheck (EasyTouch GCU, Bioptik Technology Inc., Taiwan) [5]. 
Prior to performing the experimental procedure, rats were anesthetized with rodent anesthesia 
(160095, Kepro™, Netherlands) with the dose of 30mg/kg body weight and xylazine (160096, Xyla™, 
Netherlands) at the dose of 5 mg/kg body weight applied intramuscularly on the gluteus muscle during the 
installation of the orthodontic appliance in their mouth. Nickel Titanium (NiTi) closed coil spring (American 
Orthodontics, Sheboygan, WI, USA) was mounted between maxillary first molar and the incisors with the 
light force 10gf/mm2 for OTM application (Figure 1). Animal studies were terminated on days 1, 3, 6 and 9, 
respectively. All samples were sacrificed by rodent anesthesia (60 mg/kg bw of ketamine and xylazine 3 mg/kg 
bw). Rat's premaxilla were dissected and placed in 10% formalin for four days. After the fixation, the springs 
were removed, and the premaxillae were decalcified with 5% nitric acid for two days. The decalcified 
premaxillae were fixed again in the same manner for another three days. The samples underwent tissue 
processing according to the previous method [12,16]. 
 
 
Figure 1. The orthodontic tooth movement in rats was delivered by using NiTi closed coil spring. 
 
Samples were then examined by immunohistochemical staining by an indirect technique using a 3.3'-
diaminobenzidine stain kit (DAB) (PierceTM DAB Substrate Paint Kit 34002, Thermo Fisher Scientific Inc, 
Waltham, MA, USA) and antibodies (Abcam plc, Cambridge, United Kingdom) which were monoclonal 
antibody anti-RANKL antibody [C1] (ab239607) and polyclonal antibody anti-osteoprotegerin (OPG) 
antibody (ab203061). RANKL and OPG were examined in the compression side of OTM, the mesial of left 
maxillary molar. Next, the cell was ready for microscopy analysis. All these measurements were done by two 
blinded observers in 5 different visual fields using Nikon H600L light microscope (Nikon Corp. Tokyo, Japan) 
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at 400x magnification with a 300 megapixels Fi2 DS digital camera and image processing software from Nikon 
Image System (Nikon Corp. Tokyo, Japan) [12,16]. 
 
Data Analysis 
The data were analyzed by Statistical Package for the Social Sciences 20.0 software (SPSS for 
Windows, SPSS, Chicago, USA). Descriptive statistics were given as means and standard deviation (SD). One-
way Analysis of Variance (ANOVA) and Tukey Honest Significant Difference (HSD) for post hoc (p<0.05) 
were performed based on Shapiro-Wilk and Levene's test (p>0.05) to compare the osteoclast number and 
RANKL expression between groups. 
 
Ethical Aspects 
Ethical clearance was obtained from the Research Ethics Committee of the Faculty of Dental 
Medicine, Airlangga University, Surabaya, Indonesia (136/KKEPK.FKG/IX/2014). 
 
Results 
In this study, RANKL expression was observed in the normoglycemic group (N) and the 
hyperglycemic group (H). RANKL expression was observed in the osteoblast of alveolar bone in periodontal 
tissue of each study group (Figure 2). 
 
 
Figure 2. The immunohistochemistry result showed a positive expression (brown color) of RANKL in 
osteoblast of alveolar bone in the periodontal tissue (black arrow) with 400x magnification by using a 
light microscope. A. H1; B. H3; C. H6; D. H9 in the hyperglycemic group and in the normoglycemic 
group:  E. N1; F. N3; G. N6; H. N9. 
 
The mean results of RANKL expression in the hyperglycemic group were higher compared to the 
normoglycemic group (N). RANKL expression in the normoglycemic group has increased on day 3 (N3), and 
day 6 (N6) then decreased on day 9 (N9). Whereas, in the hyperglycemic group (H), RANKL expression has 
continued to increase from day 1 (H1) to day 9 (H9), respectively. The highest mean value of RANKL 
expression in the normoglycemic group was found on day 6 (N6) and the lowest mean happened on day 1 (N1). 
As for the hyperglycemic group, the highest expression of RANKL is found in day 9 (H9), and the lowest mean 
occurs on day 1 (H1). Based on the data obtained, One-way ANOVA was performed and the result showed a 
significant difference between N groups and H groups (p=0.001). To find out in detail which group was 
significantly different, the Tukey HSD test was done. The analysis showed that there were significant 
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differences in RANKL expression between the experimental groups on days 1 (P1) and 9 (P9) (p <0.05) (Table 
1). 
 
Table 1. The mean and standard deviation of RANKL expression between groups. 
Days Groups Mean (SD) p-value 
1 Normoglycemic 1 4.75 ± 1.500 0.002* 
 Hyperglycemic 1 11.00 ± 1.633  
3 Normoglycemic 3 11.25 ± 2.875 0.145 
 Hyperglycemic 3 15.00 ± 2.161  
6 Normoglycemic 6 15.75 ± 1.258 1.000 
 Hyperglycemic 6 16.25 ± 1.500  
9 Normoglycemic 9 9.25 ± 1.893 0.001* 
 Hyperglycemic 9 18.50 ± 1.915  
Tukey Honest Significant Difference; *Statistically Significant. 
 
Furthermore, OPG expression was found positively expressed in the osteoblast of alveolar bone in 
each group (Figure 3). The mean results of OPG expression in the hyperglycemic group are lower compared to 
the normoglycemic group. OPG expression in the normoglycemic group decreased on day 3 (N3) and day 6 
(N6) then increases in day 9 (N9). Whereas, in the hyperglycemic group (H), OPG expression was decreased. 
The highest mean value of OPG expression in the normoglycemic group was found on day 1 (N1). Meanwhile, 
the lowest mean of OPG expression occurred on day 6 in the normoglycemic group (N6). As for the 
hyperglycemic group, the highest mean of OPG expression was found in day 1 (H1). In addition, the lowest 
OPG expression was discovered on day 9 in the hyperglycemic group (H9). Based on the data obtained, One-
way ANOVA was performed, the result showed a significant difference between the normoglycemic and 
hyperglycemic groups. The same as RANKL expression, in finding out in the detail which group was 
significantly different, the Tukey HSD test was done. The analysis showed that there were significant 
differences in OPG expression between groups on day 1, 3, and 9 (p<0.05) (Table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The immunohistochemistry result shows a positive expression (brown color) of OPG in 
osteoblast of alveolar bone in the periodontal tissue (black arrow) with 400x magnification using a 
light microscope. A. H1; B. H3; C. H6; D. H9 in the hyperglycemic group and in the normoglycemic 
group:  E. N1; F. N3; G. N6; H. N9. 
A 
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Table 2. The mean and standard deviation of OPG expression between groups. 
Days Groups Mean (SD) p-value 
1 Normoglycemic 1 18.00 ± 1.826 0.008* 
 Hyperglycemic 1 13.50 ± 2.646  
3 Normoglycemic 3 14.25 ± 1.258 0.001* 
 Hyperglycemic 3 7.25 ± 1.708  
6 Normoglycemic 6 9.25 ± 1.258 0.064 
 Hyperglycemic 6 5.75 ± 0.957  
9 Normoglycemic 9 13.75 ± 0.957 0.001* 
 Hyperglycemic 9 2.25 ± 0.957  
Tukey Honest Significant Difference; *Statistically Significant. 
 
Discussion 
The success of OTM depends on the balance of alveolar bone remodeling process that consisted of 
bone resorption in the compression side and bone resorption in tensile side in which hyperglycemia can inhibit 
this process. STZ successfully induced the hyperglycemia condition in rats. The rat with hyperglycemic 
condition confirmed with the blood sugar levels ≥ 250 mg / dL. Previous studies also support our study that 
mentioned STZ could be used to induce hyperglycemic conditions in rats [5,7]. 
In this study, RANKL and OPG were examined in the compression side of OTM in the mesial of left 
maxillary molar (Figure 1). In the hyperglycemic group, there was an increase in RANKL expression on day 3 
(H3) and day 6 (H6) compared to day 1 (H1), then continued to increase on day 9 (H9). The increased RANKL 
expression due to the force of OTM pressure leads to cellular feedback characterized by the increased pro-
inflammatory cytokines, which stimulates RANKL expression [18]. 
RANKL will bind to RANK in the osteoclast precursors, which triggers osteoclast differentiation and 
proliferation, activating the osteoclasts. Mature and active osteoclasts will lead to bone resorption [18-20]. As 
soon as the force of OTM pressure is applied, the inflammatory cells, osteoclasts and osteoblast progenitors 
begin to appear. This phase lasts between 24 hours to 2 days as the initial stage of tooth movement in the 
socket. Meanwhile, osteoclasts are first discovered in the area afflicted by pressure during 36-72 hours after 
OTM [21-23]. 
Previous studies stated that RANKL expression should decrease on day 7, followed by an increased 
OPG expression due to the reduced OTM force in an animal model [20,23]. Meanwhile, in this study, RANKL 
expression continued to increase and OPG expression decreased until day 9 in the hyperglycemic group. Based 
on the results in this study, it reveals that there are differences in RANKL expression between groups. 
Whereas, there is a significant increase in RANKL expression in the hyperglycemic groups on day 1 and 9 (H1 
and H9). There is no any decreased RANKL expression on day 9 in the normoglycemic group (N9). The 
increased RANKL expression is caused by hyperglycemia condition, which can enhance the production of pro-
inflammatory cytokines and the increased RANKL expression plays an essential role in osteoclast proliferation 
and differentiation [24]. 
In this study, we found that OPG expression in the hyperglycemic group decreased on day 3 (H3) and 
day 6 (H6), compared to day 1 (H1), then decreased on day 9 (H9). The increased production of pro-
inflammatory cytokines causes decreased OPG expression under hyperglycemic conditions during the OTM, 
which can inhibit the OPG expression [18]. The decreased OPG expression on day 9 in hyperglycemic rats 
with OTM (H9) is led by decreased cytokine production. OPG will inhibit RANKL binding with RANK in 
osteoclast precursor and stimulate osteoclast apoptosis; thus, it inhibits osteoclastogenesis. The low ratio of 
RANKL/OPG expression indicates slow tissue regeneration or bone remodeling [18,25]. These results are 
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consistent with the in vivo studies using a hyperglycemic mouse model, which mentioned that hyperglycemia 
condition stimulates the pro-inflammatory cytokine that enhances bone resorption and inhibits bone formation 
through the enhancement of osteoclast differentiation and proliferation [25]. 
Some authors reported that the increased mRNA level of Interleukin-1 (IL-1), TNF-α, and RANKL 
and RANK in hyperglycemic conditions could stimulate the maturation of osteoclast that can prolong the 
duration of alveolar bone resorption and inhibit the bone formation [26,27]. 
 
Conclusion 
There was a significant increase in RANKL expression and decrease of OPG expression in 
hyperglycemic rats as documented immunohistochemically. In addition, a hyperglycemic condition in Wistar 
rats during OTM might affect alveolar bone remodeling. 
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